← Leaderboards
Silke Nuber
Brigham And Women'S Hospital
$3,489,890
Attributed
$3,732,712
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2017–24$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,732,712 · 3
By mechanism
R01$1,902,515 · 1
RF1$1,344,552 · 1
R21$485,645 · 1
Top collaborators
- Dennis J Selkoe2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Jie Shen$46,115,873
- Gary P. H. Ho$1,466,040
- John W Hanna$5,457,757
- Dennis J Selkoe$33,298,694
- Vikram Khurana$7,485,027
Others in their field
Other Emerging Leaders on “Vesicle”
- Lisa Morici · Tulane University Of Louisiana$8,296,098
- David Aaron Routenberg · Meso Scale Diagnostics, Llc$8,292,690
- Avnesh Sinh Thakor · Stanford University$7,297,208
- Shigeki Watanabe · Johns Hopkins University$7,166,730
- Jacqueline Burre · Weill Medical Coll Of Cornell Univ$7,119,085
- Erez Eitan · Neurodex Inc$5,817,015
Research focus
VesicleParkinson DiseasePathway InteractionsTremorBrainCellsMutantPathologicPhenotypeSynapsesExperimental StudyPhysiologicalMonomerMembraneAlpha SynucleinMotor DeficitMutationMaleIn VivoHomeostasisLipidsMotorGrantEstrogens
Grant awards (8)
Biologically Novel Mouse Models of PD with Progressive Synucleinopathy and Early-Onset Tremor and Motor Deficits Responsive to L-DOPA$1,344,552
RF1 · FY2024 · NS · contact PI
Biologically novel mouse models of PD with progressive synucleinopathy and early-onset tremor and motor deficits responsive to L-DOPA$380,503
R01 · FY2023 · NS · contact PI
Biologically novel mouse models of PD with progressive synucleinopathy and early-onset tremor and motor deficits responsive to L-DOPA$380,503
R01 · FY2022 · NS · contact PI
Biologically novel mouse models of PD with progressive synucleinopathy and early-onset tremor and motor deficits responsive to L-DOPA$380,503
R01 · FY2021 · NS · contact PI
Biologically novel mouse models of PD with progressive synucleinopathy and early-onset tremor and motor deficits responsive to L-DOPA$380,503
R01 · FY2020 · NS · contact PI
Biologically novel mouse models of PD with progressive synucleinopathy and early-onset tremor and motor deficits responsive to L-DOPA$380,503
R01 · FY2019 · NS · contact PI
Shifting Multimers: New mouse and culture models of α-synuclein truncation by calpain in PD$220,635
R21 · FY2018 · NS · contact PI
Shifting Multimers: New mouse and culture models of α-synuclein truncation by calpain in PD$265,010
R21 · FY2017 · NS · contact PI